Matches in Wikidata for { <http://www.wikidata.org/entity/Q33416533> ?p ?o ?g. }
- Q33416533 description "2014 nî lūn-bûn" @default.
- Q33416533 description "2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած" @default.
- Q33416533 description "2014 թվականի հուլիսին հրատարակված գիտական հոդված" @default.
- Q33416533 description "2014年の論文" @default.
- Q33416533 description "2014年学术文章" @default.
- Q33416533 description "2014年学术文章" @default.
- Q33416533 description "2014年学术文章" @default.
- Q33416533 description "2014年学术文章" @default.
- Q33416533 description "2014年学术文章" @default.
- Q33416533 description "2014年學術文章" @default.
- Q33416533 description "2014年學術文章" @default.
- Q33416533 description "2014年學術文章" @default.
- Q33416533 description "2014年學術文章" @default.
- Q33416533 description "2014年學術文章" @default.
- Q33416533 description "2014年學術文章" @default.
- Q33416533 description "2014년 논문" @default.
- Q33416533 description "article científic" @default.
- Q33416533 description "article scientific" @default.
- Q33416533 description "article scientifique (publié 2014)" @default.
- Q33416533 description "articol științific" @default.
- Q33416533 description "articolo scientifico" @default.
- Q33416533 description "artigo científico (publicado na 2014)" @default.
- Q33416533 description "artigo científico (publicado na 2014)" @default.
- Q33416533 description "artigo científico" @default.
- Q33416533 description "artikel ilmiah" @default.
- Q33416533 description "artikull shkencor" @default.
- Q33416533 description "artikulong pang-agham" @default.
- Q33416533 description "artykuł naukowy" @default.
- Q33416533 description "artículo científico publicado en 2014" @default.
- Q33416533 description "artículu científicu espublizáu en 2014" @default.
- Q33416533 description "bilimsel makale" @default.
- Q33416533 description "bài báo khoa học" @default.
- Q33416533 description "mokslinis straipsnis" @default.
- Q33416533 description "naučni članak" @default.
- Q33416533 description "scienca artikolo" @default.
- Q33416533 description "scientific article published on 9 July 2014" @default.
- Q33416533 description "scientific article published on 9 July 2014" @default.
- Q33416533 description "scientific article published on 9 July 2014" @default.
- Q33416533 description "teaduslik artikkel" @default.
- Q33416533 description "tieteellinen artikkeli" @default.
- Q33416533 description "tudományos cikk" @default.
- Q33416533 description "vedecký článok" @default.
- Q33416533 description "vetenskaplig artikel" @default.
- Q33416533 description "videnskabelig artikel (udgivet 2014)" @default.
- Q33416533 description "vitenskapelig artikkel" @default.
- Q33416533 description "vitskapeleg artikkel" @default.
- Q33416533 description "vědecký článek" @default.
- Q33416533 description "wetenschappelijk artikel" @default.
- Q33416533 description "wissenschaftlicher Artikel" @default.
- Q33416533 description "επιστημονικό άρθρο" @default.
- Q33416533 description "мақолаи илмӣ" @default.
- Q33416533 description "мақолаи илмӣ" @default.
- Q33416533 description "наукова стаття, опублікована в липні 2014" @default.
- Q33416533 description "научна статия" @default.
- Q33416533 description "научная статья" @default.
- Q33416533 description "научни чланак" @default.
- Q33416533 description "научни чланак" @default.
- Q33416533 description "מאמר מדעי" @default.
- Q33416533 description "سائنسی مضمون" @default.
- Q33416533 description "مقالة علمية نشرت في 9 يوليو 2014" @default.
- Q33416533 description "مقالهٔ علمی" @default.
- Q33416533 description "২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q33416533 description "บทความทางวิทยาศาสตร์" @default.
- Q33416533 description "სამეცნიერო სტატია" @default.
- Q33416533 name "Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma" @default.
- Q33416533 name "Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma" @default.
- Q33416533 name "Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma" @default.
- Q33416533 type Item @default.
- Q33416533 label "Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma" @default.
- Q33416533 label "Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma" @default.
- Q33416533 label "Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma" @default.
- Q33416533 prefLabel "Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma" @default.
- Q33416533 prefLabel "Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma" @default.
- Q33416533 prefLabel "Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma" @default.
- Q33416533 P1433 Q33416533-8FF0E825-B625-44AC-A4A4-7BC73F970C33 @default.
- Q33416533 P1476 Q33416533-D34323DC-8C60-4DB6-9120-59BDE713A715 @default.
- Q33416533 P2093 Q33416533-15C4D1CF-EF7E-4991-8C37-3ED750A2A99D @default.
- Q33416533 P2093 Q33416533-810B418E-AD20-434E-BFA9-7E35D1E10EA3 @default.
- Q33416533 P2093 Q33416533-A7ECCFCF-8883-44B6-A26A-12C247B18375 @default.
- Q33416533 P2093 Q33416533-BEB47FDD-A000-4EC7-8C66-728A35E25C6B @default.
- Q33416533 P2093 Q33416533-DD159732-8B87-46E0-8D2A-72FAE185A15B @default.
- Q33416533 P2860 Q33416533-104F0F76-64AF-4815-B0F1-B0A1C7367E84 @default.
- Q33416533 P2860 Q33416533-181613B7-631D-402C-9521-D6F9EF4E5E50 @default.
- Q33416533 P2860 Q33416533-229A283E-4466-4CA9-A36A-A29A3AF612CA @default.
- Q33416533 P2860 Q33416533-24D2B7CC-51FF-4BC8-9B4A-D6ACB2F269B1 @default.
- Q33416533 P2860 Q33416533-348073C3-61BF-4257-9785-0ED7278ABD3A @default.
- Q33416533 P2860 Q33416533-3A041E31-5497-4A00-A83D-8009A87D1BEB @default.
- Q33416533 P2860 Q33416533-4176FA8D-51C3-4B4C-A3D1-1F341C0EDC15 @default.
- Q33416533 P2860 Q33416533-47671B2A-CA81-4DD7-9131-5DA3A38A7671 @default.
- Q33416533 P2860 Q33416533-48B382F3-F232-4DA9-BC34-F245A5CECD8C @default.
- Q33416533 P2860 Q33416533-4B7A1077-133C-4CAC-B57C-CB472D2A8E2D @default.
- Q33416533 P2860 Q33416533-576A8A27-070E-4B21-AEC8-F8C40773765C @default.
- Q33416533 P2860 Q33416533-5B24DBAE-5CC2-4671-A516-B9A6B703DCD7 @default.
- Q33416533 P2860 Q33416533-5C51F444-8387-4A78-9522-65016243AE24 @default.
- Q33416533 P2860 Q33416533-5E3F672C-7A73-40FA-8EDD-A8306871194D @default.
- Q33416533 P2860 Q33416533-5E8F7BD8-F539-4B62-8A9B-AAC4DCF22212 @default.
- Q33416533 P2860 Q33416533-61C1C1BF-D02E-4EE2-8E72-B67BEBC827C4 @default.
- Q33416533 P2860 Q33416533-62B5B789-6E55-4BC5-92B0-7F8453DBDF98 @default.
- Q33416533 P2860 Q33416533-63CD71CD-A23C-4DEE-B002-CC6919A6796D @default.
- Q33416533 P2860 Q33416533-63D702CA-0772-4E9A-904B-2B0ADF48F75D @default.